Biopolymeric mucoadhesive bilayer patch of pravastatin sodium for Buccal delivery and treatment of patients with atherosclerosis

References

• Maurya SK, Pathak K, Bali V. (2010). Therapeutic potential of mucoadhesive drug delivery systems–an updated patent review. Recent Pat Drug Deliv Formul, 4:256–265.
   PubMedGoogle Scholar
• Rathbone M, Drummond B, Tucker B. (1994). The oral cavity as a site for systemic drug delivery. Adv Drug Deli Rev, 13: 1–22.
   Web of Science ®Google Scholar
• Squier CA, Wertz PW. (1999) Structure and function of the oral mucosa and implications for drug delivery. In: Rathbone MJ: (eds.) Oral mucosal drug delivery. Marcel Dekker. Inc. New York. 1–26.
   Google Scholar
• Nagai T, Konishi R. (1987). Buccal/gingival drug delivery systems. J Control Rel. 6, 353–360.
   Google Scholar
• Ishida M, Nambu N, Nagai T. (1983). Ointment-type oral mucosal dosage form of Carbopol containing prednisolone for treatment of aphtha. Chem Pharm Bull, 31:1010–1014.
   PubMed Web of Science ®Google Scholar
• Gurny R, Meyer JM, Peppas NA. (1984). Bioadhesive intraoral release systems: design, testing and analysis. Biomaterials, 5:336–340.
   PubMed Web of Science ®Google Scholar
• Ponchel G, Touchard F, Duchene D, Peppas NA. (1987). Bioadhesive analysis of controlled-release systems: I Fracture and interpretation analysis in poly (acrylic acid) containing systems. J Control Rel, 5:129–141.
   Google Scholar
• Berthold A, Cremer K, Kreuter J. (1996). Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J Control Rel, 39: 17–25.
   Web of Science ®Google Scholar
• Voorspoels J, Remon JP, Eechaute W, De Sy W. (1996). Buccal absorption of testosterone and its esters using a bioadhesive tablet in dogs. Pharm Res, 13:1228–1232.
   PubMed Web of Science ®Google Scholar
• Senel S, Ikinci G, Kas S, Yousefi-Rad A, Sargon MF, Hincal AA. (2000). Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int J Pharm, 193:197–203.
   PubMed Web of Science ®Google Scholar
• Yajaman S, Ketousetuo K, Bandyopadhyay AK. (2006) Buccal bioadhesive drug delivery - A promising option for orally less efficient drugs. J Controll Rel. 114: 15–40.
   PubMed Web of Science ®Google Scholar
• Llabot JM, Manzo RH, Allemandi DA. (2002). Double-layered mucoadhesive tablets containing nystatin. AAPS PharmSciTech, 3:E22.
   PubMedGoogle Scholar
• Tsujita Y, Watanabe Y. (1989). Pravastatin sodium: a novel cholesterol-lowering agent that inhibits hmg-coa reductase. Cardiovascular Drug Reviews. 7: 110–126.
   Google Scholar
• Kumar M, Talwar N, Raghuvanshi RS, Rampal AS. (2005). Controlled release drug delivery system of pravastatin, US Patent 0089572 A1.
   Google Scholar
• Boyong LI, Nangia A, Dely A, Wong D. (2003). Stable pharmaceutical compositions containing pravastatin, WO Patent 03/000239.
   Google Scholar
• Shidhaye SS, Thakkar PV, Dand NM, Kadam VJ. (2010). Buccal drug delivery of pravastatin sodium. AAPS PharmSciTech, 11:416–424.
   PubMed Web of Science ®Google Scholar
• Jani GK, Shah DP, Prajapati VD, Jain VC. (2009). Gums and mucilages: versatile excipients for pharmaceutical formulations. Asian J Pharmaceut Sci. 4: 309–323.
   Google Scholar
• Nafee NA, Boraie MA, Ismail FA, Mortada LM. (2003). Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. Acta Pharm, 53:199–212.
   PubMedGoogle Scholar
• Cui Z, Mumper RJ. (2002). Buccal transmucosal delivery of calcitonin in rabbits using thin-film composites. Pharm Res, 19:1901–1906.
   PubMed Web of Science ®Google Scholar
• Peh KK, Wong CF. (1999). Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties. J Pharm Pharm Sci, 2:53–61.
   PubMed Web of Science ®Google Scholar
• Kawabata K, Matsushima N, Sasahara K. (1998). An automated method for the simultaneous determination of pravastatin and its main metabolite in human plasma by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry. Biomed Chromatogr, 12:271–275.
   PubMed Web of Science ®Google Scholar
• Bottenberg P, Cleymaet R, Muynek CD, Remon JP, Coomans D, Slop D. (1991). Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use. J Pharm Pharmacol, 43:457–464.
   PubMed Web of Science ®Google Scholar
• Oliviera AG, de Giacomelli FC, Giacomelli C, Spinelli A. (2005). Microstructure and surface composition effects on the transpassivation of NiTi wires for implant purposes. J Braz Chem Soc, 16: 131–138.
   Web of Science ®Google Scholar
• Dortunç B, Ozer L, Uyanik N. (1998). Development and in vitro evaluation of a buccoadhesive pindolol tablet formulation. Drug Dev Ind Pharm, 24:281–288.
   PubMed Web of Science ®Google Scholar
• Jasti BR, Zhou S, Mehta RC, Li X. (2000). Permeability of antisense oligonucleotide through porcine buccal mucosa. Int J Pharm, 208:35–39.
   PubMed Web of Science ®Google Scholar
• Narendra C, Srinath MS, Prakash Rao B. (2005). Development of three layered buccal compact containing metoprolol tartrate by statistical optimization technique. Int J Pharm, 304:102–114.
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123–133.
   PubMed Web of Science ®Google Scholar
• Veuillez F, Kalia YN, Jacques Y, Deshusses J, Buri P. (2001). Factors and strategies for improving buccal absorption of peptides. Eur J Pharm Biopharm, 51:93–109.
   PubMed Web of Science ®Google Scholar
• Kitano M, Maitani Y, Takayama K, Nagai T. (1998). Buccal absorption through golden hamster cheek pouch in vitro and in vivo of 17β-estradiol from hydrogels containing three types of absorption enhancers. Int J Pharm. 174: 19–28.
   Web of Science ®Google Scholar
• Hokama N, Hobara N, Kameya H, Ohshiro S, Sakanashi M. (1999). Rapid and simple micro-determination of carvedilol in rat plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl, 732:233–238.
   PubMed Web of Science ®Google Scholar
• Gavini E, Hegge AB, Rassu G, Sanna V, Testa C, Pirisino G et al. (2006). Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies. Int J Pharm, 307:9–15.
   PubMed Web of Science ®Google Scholar
• Otter K, Mignat C. (1998). Determination of pravastatin in human plasma by high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl, 708:235–241.
   PubMed Web of Science ®Google Scholar
• Moffat AC, Osselton MD, Widdop B. (2005). Monograph-Pravastatin sodium, HMG Coenzyme reductase inhibitor. Clarke’s analysis of drugs and poisons, London, UK: Pharmaceutical press.
   Google Scholar
• Chast F, Bardin C, Sauvageon-Martre H, Callaert S, Chaumeil JC. (1991). Systemic morphine pharmacokinetics after ocular administration. J Pharm Sci, 80:911–917.
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Nakayama A, Oda M, Takada M, Attwood M. (1995). Drug release from mucosal adhesive tablets of chitosan and sodium alginate. Int J Pharm. 118: 257–263.
   Web of Science ®Google Scholar
• Nakayama S, Sakashita M, Tonooka M, Gotoh H, Yasuhara H, Sakamoto K. (1983). Experimental hyperlipidemia and atherosclerosis induced by cholesterol diet in SPF Japanese white rabbits. Jpn J Pharmacol, 33:279–289.
   PubMedGoogle Scholar
• Sakamoto K, Yamauchi M, Nakayama S, Tsuruzoe N, Sakashita M, Fujikawa Y. (1987). [Effect of NIP-200 on hyperlipidemia and atherosclerosis in cholesterol-fed rabbits]. Nippon Yakurigaku Zasshi, 90:187–193.
   PubMed Web of Science ®Google Scholar
• Kolodgie FD, Katocs AS Jr, Largis EE, Wrenn SM, Cornhill JF, Herderick EE et al. (1996). Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol. Methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type. Arterioscler Thromb Vasc Biol, 16:1454–1464.
   PubMed Web of Science ®Google Scholar
• Yong CS, Jung JH, Rhee JD, Kim CK, Choi HG. (2001). Physicochemical characterization and evaluation of buccal adhesive tablets containing omeprazole. Drug Dev Ind Pharm, 27:447–455.
   PubMed Web of Science ®Google Scholar
• Nafee NA, Ismail FA, Boraie NA, Mortada LM. (2004). Mucoadhesive delivery systems. II. Formulation and in-vitro/in-vivo evaluation of buccal mucoadhesive tablets containing water-soluble drugs. Drug Dev Ind Pharm, 30:995–1004.
   PubMed Web of Science ®Google Scholar
• Andrews GP, Laverty TP, Jones DS. (2009). Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm, 71:505–518.
   PubMed Web of Science ®Google Scholar
• Khan TA, Peh KK, Ch’ng HS. (2000). Mechanical, bioadhesive strength, biological evaluations of chitosan films for wound dressing. J Pharm Pharmaceu Sci. 3: 303–311.
   Web of Science ®Google Scholar
• Desai KG, Kumar TM. (2004). Preparation and evaluation of a novel buccal adhesive system. AAPS PharmSciTech, 5:e35.
   PubMed Web of Science ®Google Scholar
• Aungst B, Rogers N. (1989). Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int J Pharm. 53: 227–235.
   Web of Science ®Google Scholar
• Shojaei AH, Berner B, Xiaoling L. (1998). Transbuccal delivery of acyclovir: I. In vitro determination of routes of buccal transport. Pharm Res, 15:1182–1188.
   PubMed Web of Science ®Google Scholar
• Agarwal V, Mishra B. (1999). Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev Ind Pharm, 25:701–709.
   PubMed Web of Science ®Google Scholar
• Attia MA, El-Gibaly I, Shaltout SE, Fetih GN. (2004). Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels. Int J Pharm, 276:11–28.
   PubMed Web of Science ®Google Scholar
• Singh B, Ahuja N. (2002). Development of buccoadhesive hydrophilic matrices of diltiazem hydrochloride: optimization of bioadhesion, dissolution and diffusion parameters. Drug Dev Ind Pharm. 28: 431–444.
   PubMed Web of Science ®Google Scholar
• Kuroda M, Matsumoto A, Itakura H, Watanabe Y, Ito T, Shiomi M et al. (1992). Effects of pravastatin sodium alone and in combination with cholestyramine on hepatic, intestinal and adrenal low density lipoprotein receptors in homozygous Watanabe heritable hyperlipidemic rabbits. Jpn J Pharmacol, 59:65–70.
   PubMedGoogle Scholar